Home/Filings/4/0001209191-18-013682
4//SEC Filing

Conchie Stephen 4

Accession 0001209191-18-013682

CIK 0001180262other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 9:13 PM ET

Size

15.6 KB

Accession

0001209191-18-013682

Insider Transaction Report

Form 4
Period: 2018-02-22
Conchie Stephen
VP, Gen. Mgr. - Southeast Asia
Transactions
  • Award

    Stock Appreciation Rights

    2018-02-22+4,4047,340 total
    Exercise: $30.44From: 2018-03-02Exp: 2025-03-02Common Stock (4,404 underlying)
  • Award

    Stock Appreciation Rights

    2018-02-22+1,5223,044 total
    Exercise: $67.09From: 2018-08-05Exp: 2026-05-05Common Stock (1,522 underlying)
  • Award

    Common Stock

    2018-02-26+4,6344,634 total
  • Award

    Stock Appreciation Rights

    2018-02-22+2,8252,825 total
    Exercise: $57.19From: 2018-02-27Exp: 2027-02-27Common Stock (2,825 underlying)
  • Award

    Stock Appreciation Rights

    2018-02-22+1,0482,096 total
    Exercise: $62.51From: 2018-05-09Exp: 2026-05-09Common Stock (1,048 underlying)
Footnotes (5)
  • [F1]Consists of restricted stock units ("RSU") under the Herbalife Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Ltd. common stock on vesting. This award will vest 20% each on February 26, 2019 and February 26, 2020, and 60% on February 26, 2021.
  • [F2]On March 2, 2015, the reporting person was granted an award of 7,340 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2017 was met, resulting in 4,404 SARs which will vest on March 2, 2018.
  • [F3]On May 9, 2016, the reporting person was granted an award of 5,240 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 1,048 SARs which will vest on May 9, 2018.
  • [F4]On August 5, 2016, the reporting person was granted an award of 7,610 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 1,522 SARs which will vest on August 5, 2018.
  • [F5]On February 27, 2017, the reporting person was granted an award of 14,124 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2017, 2018 and 2019. The performance criteria for 2017 was met, resulting in 2,825 SARs which will vest on February 27, 2018.

Issuer

HERBALIFE LTD.

CIK 0001180262

Entity typeother

Related Parties

1
  • filerCIK 0001661500

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 9:13 PM ET
Size
15.6 KB